In mouse models, the TIGIT and PD-1 pathways are mechanistically interdependent, and co-blockade of TIGIT and PD-L1 has been shown to synergistically elicit anti-tumour T cell responses9,10. The gene discussed is TIGIT; the disease is neoplasm.